Innovations in artificial intelligence are rapidly transforming drug discovery and genome engineering. Recent reports highlight AI/machine learning applications optimizing genome editing outcomes and generating novel antibiotic structures. Generative AI models developed at MIT created millions of novel antibiotics, with several candidates validated experimentally, demonstrating AI's powerful role in identifying efficacious compounds and accelerating therapeutic development.